ebomi
Colour theme
Sign in
Insider · CIK 0001721036

Oncology Impact Fund (Cayman) Management L.P.

CIK 0001721036 Name as filed on the most recent filing

Filed as Oncology Impact Fund (Cayman) Management L.P. (57)

187 transaction lines · from 57 filings · filed 2017-11-06 to 2025-12-04 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2021-11-30 S, Open-market sale iTeos Therapeutics, Inc.ITOS 339,588, disposed Open Form 4 filing 0001209191-21-067705
2021-11-29 S, Open-market sale iTeos Therapeutics, Inc.ITOS 2 lines 598,543, disposed Open Form 4 filing 0001209191-21-067146
2021-11-26 S, Open-market sale iTeos Therapeutics, Inc.ITOS 2 lines 758,282, disposed Open Form 4 filing 0001209191-21-067146
2021-11-24 S, Open-market sale iTeos Therapeutics, Inc.ITOS 3 lines 2,206,510, disposed Open Form 4 filing 0001209191-21-066854
2021-11-23 S, Open-market sale iTeos Therapeutics, Inc.ITOS 2 lines 1,212,340, disposed Open Form 4 filing 0001209191-21-066854
2021-11-22 S, Open-market sale iTeos Therapeutics, Inc.ITOS 2 lines 1,325,817, disposed Open Form 4 filing 0001209191-21-066854
2021-10-18 S, Open-market sale iTeos Therapeutics, Inc.ITOS 280,085, disposed Open Form 4 filing 0001209191-21-060722
2021-10-15 S, Open-market sale iTeos Therapeutics, Inc.ITOS 2 lines 505,300, disposed Open Form 4 filing 0001209191-21-060722
2021-10-14 S, Open-market sale iTeos Therapeutics, Inc.ITOS 1,248,129, disposed Open Form 4 filing 0001209191-21-060489
2021-10-13 S, Open-market sale iTeos Therapeutics, Inc.ITOS 950,174, disposed Open Form 4 filing 0001209191-21-060489
2021-10-12 S, Open-market sale iTeos Therapeutics, Inc.ITOS 386,303, disposed Open Form 4 filing 0001209191-21-060489
2021-10-11 S, Open-market sale iTeos Therapeutics, Inc.ITOS 2,225,072, disposed Open Form 4 filing 0001209191-21-060235
2021-10-08 S, Open-market sale iTeos Therapeutics, Inc.ITOS 91,834, disposed Open Form 4 filing 0001209191-21-060235
2021-10-07 S, Open-market sale iTeos Therapeutics, Inc.ITOS 51,894, disposed Open Form 4 filing 0001209191-21-060235
2021-10-04 S, Open-market sale iTeos Therapeutics, Inc.ITOS 937,873, disposed Open Form 4 filing 0001209191-21-059421
2021-10-01 S, Open-market sale iTeos Therapeutics, Inc.ITOS 309,717, disposed Open Form 4 filing 0001209191-21-059421
2021-09-30 S, Open-market sale iTeos Therapeutics, Inc.ITOS 103,572, disposed Open Form 4 filing 0001209191-21-058208
2021-09-28 S, Open-market sale iTeos Therapeutics, Inc.ITOS 868,158, disposed Open Form 4 filing 0001209191-21-058208
2021-09-27 S, Open-market sale iTeos Therapeutics, Inc.ITOS 527,036, disposed Open Form 4 filing 0001209191-21-057822
2021-09-24 S, Open-market sale iTeos Therapeutics, Inc.ITOS 228,626, disposed Open Form 4 filing 0001209191-21-057822
2021-09-23 S, Open-market sale iTeos Therapeutics, Inc.ITOS 2 lines 1,728,432, disposed Open Form 4 filing 0001209191-21-057822
2021-09-22 S, Open-market sale iTeos Therapeutics, Inc.ITOS 658,784, disposed Open Form 4 filing 0001209191-21-057413
2021-09-21 S, Open-market sale iTeos Therapeutics, Inc.ITOS 902,609, disposed Open Form 4 filing 0001209191-21-057413
2021-09-20 S, Open-market sale iTeos Therapeutics, Inc.ITOS 2 lines 1,117,964, disposed Open Form 4 filing 0001209191-21-056948
2021-09-17 S, Open-market sale iTeos Therapeutics, Inc.ITOS 2,203,952, disposed Open Form 4 filing 0001209191-21-056948
2021-09-16 S, Open-market sale iTeos Therapeutics, Inc.ITOS 1,012,536, disposed Open Form 4 filing 0001209191-21-056948
2021-09-16 S, Open-market sale Cullinan Oncology, Inc.CGEM 90,783, disposed Open Form 4 filing 0001209191-21-056914
2021-09-15 S, Open-market sale iTeos Therapeutics, Inc.ITOS 2 lines 1,121,535, disposed Open Form 4 filing 0001209191-21-056412
2021-09-15 S, Open-market sale Cullinan Oncology, Inc.CGEM 187,353, disposed Open Form 4 filing 0001209191-21-056411
2021-09-14 S, Open-market sale iTeos Therapeutics, Inc.ITOS 2 lines 995,198, disposed Open Form 4 filing 0001209191-21-056412
2021-09-14 S, Open-market sale Cullinan Oncology, Inc.CGEM 207,282, disposed Open Form 4 filing 0001209191-21-056411
2021-09-13 S, Open-market sale iTeos Therapeutics, Inc.ITOS 989,097, disposed Open Form 4 filing 0001209191-21-055745
2021-09-13 S, Open-market sale Cullinan Oncology, Inc.CGEM 104,615, disposed Open Form 4 filing 0001209191-21-055726
2021-09-10 S, Open-market sale iTeos Therapeutics, Inc.ITOS 2 lines 640,691, disposed Open Form 4 filing 0001209191-21-055745
2021-09-10 S, Open-market sale Cullinan Oncology, Inc.CGEM 172,236, disposed Open Form 4 filing 0001209191-21-055726
2021-09-09 S, Open-market sale iTeos Therapeutics, Inc.ITOS 1,101,671, disposed Open Form 4 filing 0001209191-21-055745
2021-09-09 S, Open-market sale Cullinan Oncology, Inc.CGEM 402,887, disposed Open Form 4 filing 0001209191-21-055726
2021-09-08 S, Open-market sale iTeos Therapeutics, Inc.ITOS 533,948, disposed Open Form 4 filing 0001209191-21-055212

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Oncology Impact Fund (Cayman) Management L.P., insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001721036

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.